B. Braun to Showcase its Broad Pharmacy Portfolio at ASHP
ASHP--largest gathering of pharmacists in the world
BETHLEHEM, Pa., Dec. 2, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) will sponsor an exhibit theater presentation at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Orlando, FL, December 8th-10th.
The presentation, "Safe Compounding of Hazardous Drugs," will be presented by David Halterman, Director of Pharmacy, on Tuesday, December 10th from 11:30 a.m.-12:30 p.m. at the West Convention Center (end of aisle 800).
"B.Braun has made a longstanding commitment to eliminating preventable treatment errors and we are passionately committed to enhancing patient, clinician and environmental safety with products, services and education focused on sharing best clinical practices," said Rick Williamson, Vice President of Pharmaceutical Marketing at B.Braun.
B.Braun will showcase the following protective engineering device, compounding management system and CAPS® outsourcing admixture capabilities at booth (#1233) during ASHP:
- OnGuard™ Closed Medication System, a next-generation closed system drug-transfer device (CSTD), underscores B.Braun's commitment to helping protect healthcare workers from exposure to hazardous drugs. It meets the National Institute for Occupational Safety and Health definition of a CSTD in actual drug testing with antineoplastic agents. To learn more about hazardous drug exposure and to download an educational poster visit www.CytotoxicExposure.com.
- The PINNACLE® TPN Management System, which streamlines all functional areas of operation and manages all aspects of the TPN process for improved compounding efficiency and safety. The enhanced, easier-to-use Pinnacle TPN Manager Software will also be featured, which allows pharmacists to enter orders remotely using iPads.
- Sterile Admixture Outsourcing Services by CAPS®, Central Admixture Pharmacy Services, Inc. CAPS pharmacies operate 365 days a year dispensing labeled, patient-specific and anticipatory IV prescriptions to health system pharmacy customers, nationwide. CAPS is registered with the FDA.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.
SOURCE B. Braun Medical Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article